|
货号 | 品名 | 规格 | 包装 | 单价 | 货期 | 库存 |
JD200512093117 | 帕妥珠单抗 | 99.10% | 5mg | 11400元 | 咨询客服 | 3天 |
JD200512093059 | 帕妥珠单抗 | 99.10% | 1mg | 5800元 | 咨询客服 | 3天 |
性状: | Pertuzumab 是一种人源化单克隆抗体,是一种HER2二聚抑制剂。可用于治疗转移性HER2 阳性乳腺癌。 |
质量标准: | Description Pertuzumab, a humanized monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer. IC50 & Target EGFR[1] Storage Please store the product under the recommended conditions in the Certificate of Analysis. References [1]. Nahta R, et al. The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survivalof breast cancer cells. Cancer Res. 2004 Apr 1;64(7):2343-6. [2]. Scheuer W, et al. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res. 2009 Dec 15;69(24):9330-6. |